Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract

Clinical trial NCT05297760 · COMPLETED

Trial details

NCT number: NCT05297760
Sponsor: University of Zurich
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rhinitis, Allergic, Seasonal Rhinitis; Allergic, With Asthma Allergic Rhinitis Allergic Rhinitis Due to Grass Pollen Allergic Asthma

Start date: 2022-02-10
Primary completion: 2025-02-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.